HVLP – Antivirotikum pro systémové použití – CMV - Ganciclovir II.
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 16416671 | 06. 09. 2021 | PHARMOS, a.s. | 2 260 500,00 | 2 055 000,00 | 2 260 500,00 | 2 055 000,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 406_Písemná zpráva.pdf | Písemná zpráva zadavatele | 21. 09. 2021 14:36 | Dokument není zavirovaný |
List of Participants
| Show detail | |||||||
|---|---|---|---|---|---|---|---|
| PHOENIX lékárenský velkoobchod, s.r.o. | Praha | 2 054 665,00 | CZK | ||||
| PHARMOS, a.s. | Ostrava | 2 043 335,50 | CZK |
Price Actually Paid in Each Year of Performance
| 16416671 | 2023 | 752 231,01 | 683 846,37 |
| 16416671 | 2022 | 904 410,21 | 822 191,10 |
| 16416671 | 2021 | 327 104,05 | 297 367,32 |